Advertisement

Esophagus

, Volume 16, Issue 1, pp 85–92 | Cite as

Robot-assisted mediastinoscopic esophagectomy for esophageal cancer: the first clinical series

  • Masaya NakauchiEmail author
  • Ichiro Uyama
  • Koichi Suda
  • Susumu Shibasaki
  • Kenji Kikuchi
  • Shinichi Kadoya
  • Yoshinori Ishida
  • Kazuki Inaba
Original Article
  • 99 Downloads

Abstract

Background

Radical esophagectomy for esophageal cancer is associated with high morbidity, especially with pulmonary complications. Mediastinoscopic esophagectomy via a small left neck incision combined with the esophageal hiatus, without using transthoracic approach, has been reported to reduce pulmonary complication; however, from technical point of view, this approach using non-articulating, straight, long forceps is extremely challenging, especially in the middle mediastinal area. Its technical difficulties may be attenuated using da Vinci Surgical System. The aim of this study was to evaluate the feasibility and safety of robot-assisted mediastinoscopic esophagectomy.

Methods

Robot-assisted mediastinoscopic esophagectomy was performed in six patients between October 2016 and May 2017. Robotic esophageal mobilization with upper and middle mediastinal lymphadenectomy was performed via the three da Vinci Xi (Intuitive Surgical, Inc. Sunnyvale, CA) trocars placed on the 5-cm left cervical incision. Thereafter, the remaining part of radical esophagectomy was completed via a transhiatal approach.

Results

Upper and middle mediastinal lymphadenectomy was robotically completed via the transcervical approach in all cases without conversion to transthoracic approach. No postoperative complications (Clavien–Dindo classification grade ≥ III) were observed.

Conclusions

Robot-assisted mediastinoscopic esophagectomy was technically feasible and safe. Use of da Vinci Surgical System may help attenuate technical difficulties in transcervical middle mediastinal lymph node dissection.

Keywords

Esophageal cancer Robotic Esophagectomy Mediastinoscopy 

Notes

Acknowledgements

The authors are indebted to Maruzen CO., LTD. (Tokyo, Japan) for their native English speaker’s review of this manuscript. Intuitive Surgical, Inc. provided the necessary laboratory support in the preclinical cadaver study.

Author contributions

MN: assistant of surgeon, acquisition of data, drafting of manuscript. IU: operating surgeon, drafting and revision of manuscript. KS: drafting and revision of manuscript. SS: assistant of surgeon, drafting of manuscript. KK: assistant of surgeon, drafting of manuscript. SK: assistant of surgeon, drafting of manuscript. YI: drafting and revision of manuscript. KI: assistant of surgeon, drafting and revision of manuscript.

Funding information

This work was not supported by any grants or funding. All authors have no commercial association or financial involvement that might pose a conflict of interest in connection with the submitted article.

Compliance with ethical standards

Ethical statement

This study was approved by the institutional review board of Fujita Health University. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.

Conflict of interest

This work was not supported by any grants or funding. Masaya Nakauchi, Ichiro Uyama, Koichi Suda, Susumu Shibasaki, Kenji Kikuchi, Shinichi Kadoya, Yoshinori Ishida, and Kazuki Inaba have no conflicts of interest or financial ties to disclose.

Supplementary material

10388_2018_634_MOESM1_ESM.mpg (70.1 mb)
Supplementary material 1 (MPG 71832 kb)

References

  1. 1.
    Fujita H, Sueyoshi S, Tanaka T, et al. Three-field dissection for squamous cell carcinoma in the thoracic esophagus. Ann Thorac Cardiovasc Surg. 2002;8:328–35.Google Scholar
  2. 2.
    Kato K, Muro K, Minashi K, et al. Gastrointestinal oncology study group of the Japan clinical oncology. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for stage II–III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys. 2011;81:684–90.CrossRefGoogle Scholar
  3. 3.
    Gockel I, Heckhoff S, Messow CM, et al. Transhiatal and transthoracic resection in adenocarcinoma of the esophagus: does the operative approach have an influence on the long-term prognosis? World J Surg Oncol. 2005;3:40.CrossRefGoogle Scholar
  4. 4.
    Bakhos CT, Fabian T, Oyasiji TO, et al. Impact of the surgical technique on pulmonary morbidity after esophagectomy. Ann Thorac Surg. 2012;93:221–6.CrossRefGoogle Scholar
  5. 5.
    Akaishi T, Kaneda I, Higuchi N, et al. Thoracoscopic en bloc total esophagectomy with radical mediastinal lymphadenectomy. J Thorac Cardiovasc Surg. 1996;112:1533–40.CrossRefGoogle Scholar
  6. 6.
    Luketich JD, Alvelo-Rivera M, Buenaventura PO, et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg. 2003;238:486–94.Google Scholar
  7. 7.
    Biere SS, van Berge Henegouwen MI, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. 2012;379:1887–92.CrossRefGoogle Scholar
  8. 8.
    Suda K, Ishida Y, Kawamura Y, et al. Robot-assisted thoracoscopic lymphadenectomy along the left recurrent laryngeal nerve for esophageal squamous cell carcinoma in the prone position: technical report and short-term outcomes. World J Surg. 2012;36:1608–16.CrossRefGoogle Scholar
  9. 9.
    Parker M, Bowers SP, Goldberg RF, et al. Transcervical videoscopic esophageal dissection during two-field minimally invasive esophagectomy: early patient experience. Surg Endosc. 2011;25:3865–9.CrossRefGoogle Scholar
  10. 10.
    Watanabe M, Yoshida N, Karashima R, et al. Transcervical superior mediastinal lymph node dissection combined with transhiatal lower esophageal dissection before transthoracic esophagectomy: a safe approach for salvage esophagectomy. J Am Coll Surg. 2009;208:e7–9.CrossRefGoogle Scholar
  11. 11.
    Horgan S, Berger RA, Elli EF, et al. Robotic-assisted minimally invasive transhiatal esophagectomy. Am Surg. 2003;69:624–6.Google Scholar
  12. 12.
    Pop D, Venissac N, Mouroux J. Video-assisted mediastinoscopy improved radical resection for cancer in transhiatal esophagectomy. J Thorac Cardiovasc Surg. 2007;133:267–8.CrossRefGoogle Scholar
  13. 13.
    Mori K, Yamagata Y, Wada I, et al. Robotic-assisted totally transhiatal lymphadenectomy in the middle mediastinum for esophageal cancer. J Robot Surg. 2013;7:385–7.CrossRefGoogle Scholar
  14. 14.
    Fujiwara H, Shiozaki A, Konishi H, et al. Single-port mediastinoscopic lymphadenectomy along the left recurrent laryngeal nerve. Ann Thorac Surg. 2015;100:1115–7.CrossRefGoogle Scholar
  15. 15.
    Fujiwara H, Shiozaki A, Konishi H, et al. Hand-assisted laparoscopic transhiatal esophagectomy with a systematic procedure for en bloc infracarinal lymph node dissection. Dis Esophagus. 2016;29:113–31.Google Scholar
  16. 16.
    Fujiwara H, Shiozaki A, Konishi H, et al. Perioperative outcomes of single-port mediastinoscope-assisted transhiatal esophagectomy for thoracic esophageal cancer. Dis Esophagus. 2017;30:1–8.CrossRefGoogle Scholar
  17. 17.
    Suda K, Man IM, Ishida Y, et al. Potential advantages of robotic radical gastrectomy for gastric adenocarcinoma in comparison with conventional laparoscopic approach: a single institutional retrospective comparative cohort study. Surg Endosc. 2015;29:673–85.CrossRefGoogle Scholar
  18. 18.
    Mori K, Yamagata Y, Aikou S, et al. Short-term outcomes of robotic radical esophagectomy for esophageal cancer by a nontransthoracic approach compared with conventional transthoracic surgery. Dis Esophagus. 2016;29:429–34.CrossRefGoogle Scholar
  19. 19.
    Boone J, Borel Rinkes IH, van Hillegersberg R. Transhiatal robot-assisted esophagectomy. Surg Endosc. 2008;22:1139–40.CrossRefGoogle Scholar
  20. 20.
    Mori K, Yoshimura S, Yamagata Y, et al. Preclinical study of transcervical upper mediastinal dissection for esophageal malignancy by robot-assisted surgery. Int J Med Robot. 2017;13:e1750.CrossRefGoogle Scholar
  21. 21.
    Rice TW, Blackstone EH, Rusch VW. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol. 2010;17:1721–4.CrossRefGoogle Scholar
  22. 22.
    Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: 5-year experience. Ann Surg. 2009;250:187–96.CrossRefGoogle Scholar
  23. 23.
    Japan Esophageal Society. Japanese classification of esophageal cancer: part I. Esophagus. 2017;14:1–36.CrossRefGoogle Scholar
  24. 24.
    Japan Esophageal Society. Japanese classification of esophageal cancer: part II and III. Esophagus. 2017;14:37–65.CrossRefGoogle Scholar
  25. 25.
    Kurokawa Y, Sasako M, Sano T, Japan Clinical Oncology Group, et al. Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia. Br J Surg. 2015;102:341–8.CrossRefGoogle Scholar
  26. 26.
    Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662–9.CrossRefGoogle Scholar
  27. 27.
    Junginger T, Gockel I, Heckhoff S. A comparison of transhiatal and transthoracic resections on the prognosis in patients with squamous cell carcinoma of the esophagus. Eur J Surg Oncol. 2006;32:749–55.CrossRefGoogle Scholar
  28. 28.
    Ruurda JP, van der Sluis PC, van der Horst S, et al. Robot-assisted minimally invasive esophagectomy for esophageal cancer: a systematic review. J Surg Oncol. 2015;112:257–65.CrossRefGoogle Scholar
  29. 29.
    Park SY, Kim DJ, Jung HS. Robot-assisted thoracoscopic esophagectomy with extensive mediastinal lymphadenectomy: experience with 114 consecutive patients with intrathoracic esophageal cancer. Dis Esophagus. 2016;29:326–32.CrossRefGoogle Scholar
  30. 30.
    Gockel I, Kneist W, Keilmann A, et al. Recurrent laryngeal nerve paralysis (RLNP) following esophagectomy for carcinoma. Eur J Surg Oncol. 2005;31:277–81.CrossRefGoogle Scholar
  31. 31.
    Swanson SJ, Batirel HF, Bueno R, et al. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma. Ann Thorac Surg. 2001;72:1918–24.CrossRefGoogle Scholar
  32. 32.
    Scholtemeijer MG, Seesing MFJ, Brenkman HJF, et al. Recurrent laryngeal nerve injury after esophagectomy for esophageal cancer: incidence, management, and impact on short- and long-term outcomes. J Thorac Dis. 2017;9:S868–78.CrossRefGoogle Scholar

Copyright information

© The Japan Esophageal Society and Springer Japan KK, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of SurgeryFujita Health UniversityToyoakeJapan
  2. 2.Cancer Center, School of MedicineKeio UniversityTokyoJapan
  3. 3.Upper G.I. Division, Department of SurgeryHyogo College of MedicineNishinomiyaJapan

Personalised recommendations